XML 48 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Detail of Certain Accounts (Tables)
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cash and Cash Equivalents Amounts related to cash and cash equivalents held by consolidated or proportionately consolidated joint ventures and the captive insurance company, which are included in Quanta’s total cash and cash equivalents balances, were as follows (in thousands):
 March 31, 2023December 31, 2022
Cash and cash equivalents held by domestic joint ventures$17,703 $14,291 
Cash and cash equivalents held by foreign joint ventures10,010 6,277 
Total cash and cash equivalents held by joint ventures27,713 20,568 
Cash and cash equivalents held by captive insurance company34,285 35,085 
Cash and cash equivalents not held by joint ventures or captive insurance company155,117 372,852 
Total cash and cash equivalents$217,115 $428,505 
Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses consisted of the following (in thousands):
 March 31, 2023December 31, 2022
Accounts payable, trade$1,359,912 $1,302,086 
Accrued compensation and related expenses382,891 469,048 
Other accrued expenses425,371 381,995 
Accounts payable and accrued expenses$2,168,174 $2,153,129